OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 180 citing articles:

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Bei Wang, Lujin Wu, Jing Chen, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 848

Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 346

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot-Girard, Jennifer Hua, Lauriane Ulmann, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 289

Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
Baban S. Thawkar, Ginpreet Kaur
Journal of Neuroimmunology (2018) Vol. 326, pp. 62-74
Closed Access | Times Cited: 205

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
Bindu D. Paul, Marian Dix Lemle, Anthony L. Komaroff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 34
Open Access | Times Cited: 202

The Role of the Phosphorus Atom in Drug Design
Juan B. Rodríguez, Carola Gallo‐Rodriguez
ChemMedChem (2018) Vol. 14, Iss. 2, pp. 190-216
Open Access | Times Cited: 167

Adenosine and Inflammation: Here, There and Everywhere
Silvia Pasquini, Chiara Contri, Pier Andrea Borea, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7685-7685
Open Access | Times Cited: 113

Oxidative stress and regeneration
Morana Jaganjac, Lidija Milković, Neven Žarković, et al.
Free Radical Biology and Medicine (2022) Vol. 181, pp. 154-165
Closed Access | Times Cited: 103

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 87

The role of the ATP-adenosine axis in ischemic stroke
Ines Sophie Schädlich, Riekje Winzer, Joschi Stabernack, et al.
Seminars in Immunopathology (2023) Vol. 45, Iss. 3, pp. 347-365
Open Access | Times Cited: 41

Stimulation-induced increases in cerebral blood flow and local capillary vasoconstriction depend on conducted vascular responses
Changsi Cai, Jonas C. Fordsmann, Sofie Hørlyck Jensen, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 25
Open Access | Times Cited: 137

The therapeutic potential of purinergic signalling
Geoffrey Burnstock
Biochemical Pharmacology (2017) Vol. 151, pp. 157-165
Closed Access | Times Cited: 117

Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation
Gemma Manich, Mireia Recasens, Tony Valente, et al.
Neuroscience (2018) Vol. 405, pp. 118-136
Closed Access | Times Cited: 96

Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Lucas T. Woods, Deepa Ajit, Jean M. Camden, et al.
Neuropharmacology (2015) Vol. 104, pp. 169-179
Open Access | Times Cited: 93

Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Edward Beamer, Flóra Gölöncsér, Gergely Horváth, et al.
Neuropharmacology (2015) Vol. 104, pp. 94-104
Open Access | Times Cited: 91

ATP and adenosine—Two players in the control of seizures and epilepsy development
Edward Beamer, Manvitha Kuchukulla, Detlev Boison, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102105-102105
Open Access | Times Cited: 71

ATPergic signalling during seizures and epilepsy
Tobías Engel, Mariana Alves, Caroline Sheedy, et al.
Neuropharmacology (2015) Vol. 104, pp. 140-153
Closed Access | Times Cited: 87

CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17
Marta Fumagalli, Davide Lecca, Maria P. Abbracchio
Neuropharmacology (2015) Vol. 104, pp. 82-93
Open Access | Times Cited: 78

Neuroprotective effects of honokiol: from chemistry to medicine
Sylwia Talarek, Joanna Listos, Davide Barreca, et al.
BioFactors (2017) Vol. 43, Iss. 6, pp. 760-769
Closed Access | Times Cited: 70

Short- and long-term (trophic) purinergic signalling
Geoffrey Burnstock
Philosophical Transactions of the Royal Society B Biological Sciences (2016) Vol. 371, Iss. 1700, pp. 20150422-20150422
Open Access | Times Cited: 69

Purinergic signaling orchestrating neuron-glia communication
Paula Agostinho, Daniela Madeira, Liliana Dias, et al.
Pharmacological Research (2020) Vol. 162, pp. 105253-105253
Closed Access | Times Cited: 68

Nucleotides in neuroregeneration and neuroprotection
M. Teresa Miras‐Portugal, Rosa Gómez‐Villafuertes, Javier Gualix, et al.
Neuropharmacology (2015) Vol. 104, pp. 243-254
Open Access | Times Cited: 65

The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
Francesco Calzaferri, Cristina Ruiz‐Ruiz, Antonio M. G. de Diego, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2427-2465
Open Access | Times Cited: 57

Page 1 - Next Page

Scroll to top